Phio Pharmaceuticals Corp. (PHIO) › Cash & EquivalentsPhio Pharmaceuticals Corp. (PHIO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2011: $503.0K2012: $5.13M2013: $11.39M2014: $8.50M2015: $5.12M2016: $12.91M2017: $3.58M2023: $8.49M2024: $5.38M2025: $21.03M$21.03M2011Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$21.03M+290.8%2024$5.38M-36.6%2023$8.49M—2017$3.58M-72.3%2016$12.91M+152.2%2015$5.12M-39.8%2014$8.50M-25.4%2013$11.39M+122.2%2012$5.13M+919.3%2011$503.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share